BRIEF-Inovio Pharma awarded $6.1 mln sub-grant through Wistar Institute to develop DNA-based monoclonal antibodies against Zika virus

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.